Women Researcher Award
| Shailee Tiwari | |
|---|---|
| Affiliation | Shri Ramkrishna Paramhans College of Pharmacy, Maharashtra |
| Country | India |
| Scopus Author ID | 57190732577 |
| Citations | 840 |
| Documents | 40 |
| h-index | 18 |
| Research Area | Pharmacy, Medicinal Chemistry, Drug Discovery, Anticancer Research |
| Event | Indian Scientist Awards |
Shailee Tiwari
Shri Ramkrishna Paramhans College of Pharmacy, Maharashtra, India
Shailee Tiwari is a distinguished pharmaceutical researcher, educator, and medicinal chemist with expertise in anticancer drug discovery, medicinal chemistry, pharmaceutical sciences, and green synthesis methodologies. She has made significant contributions to pharmaceutical research through high-impact publications, patents, books, and innovative research projects.
Her research focuses on the design, synthesis, biological evaluation, molecular docking, and development of novel therapeutic agents targeting cancer and other diseases. Her work has gained recognition nationally and internationally through publications in reputed journals and conference presentations.
Abstract
Shailee V. Tiwari has established herself as a leading researcher in pharmaceutical sciences with extensive contributions in medicinal chemistry, green synthesis, anticancer drug development, and molecular modeling. Her research has generated significant scientific outcomes through publications, patents, books, and collaborative research activities.
Keywords
Pharmacy, Medicinal Chemistry, Anticancer Agents, Drug Discovery, Molecular Docking, Pharmaceutical Sciences, Green Chemistry, Drug Design, EGFR Inhibitors.
Introduction
Pharmaceutical research plays a critical role in discovering innovative therapeutic solutions for complex diseases. Medicinal chemistry and drug discovery have become essential areas for developing effective and targeted treatment approaches.
Research Profile
Tiwari earned her Ph.D. in Pharmacy from Babasaheb Ambedkar Marathwada University, Aurangabad. She also holds an M.Tech in Drugs and Pharmaceutics and a B.Pharm degree with first-class academic distinction.
Research Work
Her research focuses on medicinal chemistry, synthesis of bioactive heterocyclic compounds, anticancer drug discovery, molecular docking studies, ADMET prediction, pharmaceutical formulations, and green chemistry approaches.
Selected Publications
- Ultrasound Mediated One-Pot Three Component Synthesis of Thiadiazolo Pyrimidine Derivatives as Anticancer Agents, Molecules.
- Facile Synthesis of Novel Coumarin Derivatives with Antimicrobial and Docking Studies, Molecules.
Awards & Achievements
- Qualified GATE, GPAT and PET examinations.
- First Prize Winner at University and District Level Avishkar Research Competition.
Technical Skills
- Medicinal Chemistry and Drug Design.
- Molecular Docking and Computational Drug Discovery.
Research Impact
Tiwari’s research has achieved significant scientific visibility with 840 citations, 40 indexed publications, and an h-index of 18. Her studies have contributed to advances in medicinal chemistry, cancer therapeutics, and pharmaceutical innovation.
Award Suitability
Shailee V. Tiwari demonstrates outstanding contributions to pharmaceutical sciences through impactful research publications, patents, books, innovative drug discovery projects, and academic leadership. Her achievements strongly support her suitability for the Women Researcher Award.
Conclusion
Shailee V. Tiwari is a highly accomplished researcher whose contributions to medicinal chemistry, pharmaceutical sciences, and anticancer drug discovery have advanced scientific knowledge and innovation. Her research excellence, academic achievements, and commitment to healthcare advancement make her a deserving recipient of the Women Researcher Award.
External Links
References
-
- Novel Pyrido[2,3-b][1,4]Oxazine-Based EGFR-TK Inhibitors: Rational Design and Synthesis of Potent and Selective Agents Targeting Resistance Mutations in Non-Small Cell Lung Cancer. RSC Medicinal Chemistry, 2026.
https://doi.org/10.1039/D6MD00123A - Synthesis and Anticancer Activity of Diethyl (((5-(Substituted Phenyl)-1,3,4-Thiadiazol-2-yl)amino)(Quinolin-2-yl)Methyl)Phosphonate. Russian Journal of Bioorganic Chemistry, 2025.
https://doi.org/10.1134/S1068162025600418 - Synthesis and Anticancer Activity of Diethyl (((5-(Substituted Phenyl)-1,3,4-Thiadiazol-2-yl)amino)(Quinolin-2-yl)Methyl)Phosphonate. Russian Journal of Bioorganic Chemistry, 2025.
https://doi.org/10.1134/S1068162025600418
- Novel Pyrido[2,3-b][1,4]Oxazine-Based EGFR-TK Inhibitors: Rational Design and Synthesis of Potent and Selective Agents Targeting Resistance Mutations in Non-Small Cell Lung Cancer. RSC Medicinal Chemistry, 2026.